Inter Costal Catheters for Video-Assisted Thoroscopic (VATS) Lobectomy

October 1, 2010 updated by: Rigshospitalet, Denmark

Pain Relief After VATS Lobectomy Using Interoperatively Placed Inter Costal Catheters.

A pilot study to observe satisfaction of analgesia with intercostal catheters after VATS lobectomy.

Study Overview

Status

Completed

Detailed Description

Pain and satisfaction with pain treatment is investigated in a population after VATS lobectomy.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2100
        • Rigshospitalet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Consenting lung cancer patients due for elective surgery

Description

Inclusion Criteria:

Age of consent (ie age>=18) Eligible for lobectomy Able to comply Willing to register postoperatively

-

Exclusion Criteria:

  • do not understand DAnish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS (pain score 0-10))
Time Frame: Until discharge (2-4 days)
Painscore
Until discharge (2-4 days)
satisfaction (Verbal ranking scale 1-4)
Time Frame: until discharge, 2-4 days
qualitative measurement
until discharge, 2-4 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Side effects (quantitatively, see details)
Time Frame: until discharge, 2-4 days
Daily presence of, Nausea Dizziness Vomiting Sedation Pruritus
until discharge, 2-4 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2010

Primary Completion (ACTUAL)

September 1, 2010

Study Completion (ACTUAL)

September 1, 2010

Study Registration Dates

First Submitted

October 1, 2010

First Submitted That Met QC Criteria

October 1, 2010

First Posted (ESTIMATE)

October 4, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

October 4, 2010

Last Update Submitted That Met QC Criteria

October 1, 2010

Last Verified

October 1, 2010

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer Patients

3
Subscribe